Distinguished Professor Margaret Brimble is now Dame Margaret in recognition of her remarkable contribution to science, specifically to her reserch in medicinal chemistry and the development of new life saving drugs. One of her drug candidates to treat Rett and Fragile X syndromes is currently in phase three human clinical trials.
She is Chair of Organic Chemistry and Director of Medicinal Chemistry at the University of Auckland and is Principal Investigator in the Maurice Wilkins Centre for Molecular Biodiscovery. Dame Margaret also set up New Zealand's first Good Manufacturing Practice Peptide Active Pharmaceutical Ingredient Manufacturing Facility.
Professor Margaret Brimble Photo: © Dean Carruthers 2013
